# Synovial Fluid Biomarkers Pre and Post Hymovis Knee Injection

> **NCT04093232** · — · UNKNOWN · sponsor: **National Jewish Health** · enrollment: 50 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Hymovis

## Key facts

- **NCT ID:** NCT04093232
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04093232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04093232, "Synovial Fluid Biomarkers Pre and Post Hymovis Knee Injection". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04093232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
